Company intelligence / Profile preview

EpiPaws

Fort Lauderdale, Florida, United States

Ownership: Private
Employees: ~5
Development stage: Other

Overview

EpiPaws has launched an at-home epigenetic DNA test for age estimation in pets, providing more accurate results than visual/veterinary assessment. Clinical use includes enabling better preventive care decisions for aging pets. The company is expanding into research on aging and disease prevention in animals, collaborating with industry partners.

Therapeutic areas: Other
Modalities: Epigenetic biomarker testDiagnostic test (DNA swab-based for age estimation)
Industry: Molecular Diagnostics

Partnerships

Purina/9 Square Ventures (Pet Care Innovation Prize/partnering discussions)Unleashed powered by Purina (pet tech startup support)New World Angels (investment/mentorship)Florida Atlantic University Runway, NSU Levan Center (incubator/accelerator/mentorship)

Beyond the preview

Go deeper on EpiPaws.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on EpiPaws.

Explore the full profile